ING3 promotes prostate cancer growth by activating the androgen receptor

Abstract Background The androgen receptor (AR) is a major driver of prostate cancer, and increased AR levels and co-activators of the receptor promote the development of prostate cancer. INhibitor of Growth (ING) proteins target lysine acetyltransferase or lysine deacetylase complexes to the histone...

Full description

Bibliographic Details
Published in:BMC Medicine
Main Authors: Arash Nabbi, Urszula L. McClurg, Subhash Thalappilly, Amal Almami, Mahsa Mobahat, Tarek A. Bismar, Olivier Binda, Karl T. Riabowol
Format: Article
Language:English
Published: BMC 2017-05-01
Subjects:
INhibitor of growth 3
ING3
Prostate cancer
Androgen receptor
Prognostic biomarker
Oncogene
Online Access:http://link.springer.com/article/10.1186/s12916-017-0854-0

Internet

http://link.springer.com/article/10.1186/s12916-017-0854-0

Similar Items